US Medical-Dispensed Skincare in 2026: Market Data and a Wholesale Buyer’s Guide
Created on Today
Wholesale buyers of medical-grade skincare are dealing with a market that is growing again, being reshaped by acquisitions and increasingly shopped online.
This guide pulls together the latest published data on the US medical-dispensed channel, names the brands that data points to, and sets out what to check when sourcing physician-dispensed skincare wholesale, from authorised supply to pricing and compliance.
Key takeaways
- Demand is recovering: Kline reports that the US medical care provider channel grew 6% in the first half of 2026, up from 3% a year earlier.
- Brand choice matters: Kline names SkinCeuticals, ZO Skin Health and SkinBetter Science as holding significant share, and Hydrinity, Epicutis and Plated Skin Science among the fastest risers.
- Ownership is changing: Galderma has agreed to buy ZO Skin Health at a $1.5 billion enterprise value, and Puig took full ownership of ISDIN in September for about €1.2 billion.
- Online sales are growing faster than clinic sales, so buying from an authorised source and understanding price policy protect your margins and your customers.
What “Medical-Dispensed” Means
Medical-dispensed skincare, also called physician-dispensed skincare, refers to professional skincare sold mainly through dermatology, plastic surgery and medical aesthetics practices, where a provider recommends and often sells the products alongside treatments. Kline uses the term “medical-dispensed skin care” in its market series, and market-research firms often use “physician-dispensed cosmeceuticals” for the same area.
The US Market In 2026: Growth Is Back, But At a Measured Pace
Via @The NewYork Times
Kline's mid-year updates give the clearest view of channel momentum. Read together, they show a cooling in 2025 and a partial recovery in 2026.
Period | US growth reported by Kline | Source |
H1 2024 | +8% (brands sold through med spas and physicians) | Kline, Mid-Year 2024 Update |
H1 2025 | +3% | Kline, Mid-Year 2025 Update |
H1 2026 | +6% (US medical care provider channel) | Kline, Mid-Year 2026 Update |
The wording of each update differs slightly, so treat the three figures as directional rather than a perfectly consistent series. Kline’s 2026 update also reports that Canada’s provider channel declined 1% in the same half-year, which shows how differently neighbouring markets can behave.
Why Market-Size Estimates Disagree
If you search for the size of this market, you will find numbers that differ by well over 50%. The table shows published global estimates for physician-dispensed cosmeceuticals, which is a broader category than the US provider channel alone.
Via @PR Newswire
Publisher | Figure | Period |
Straits Research | US$9.14B (2025), US$9.87B (2026 est.), 8.16% CAGR to 2034 | 2025 to 2034 |
Verified Market Reports | US$16.17B (2025), 7.82% CAGR | 2025 to 2034 |
Research and Markets | US$14.89B (2026 projected) | 2026 |
Market Glass (via Research and Markets) | US$10B (2024) to US$16.2B (2030), 8.4% CAGR | 2024 to 2030 |
The spread comes from different definitions, product scope and methods, so we recommend using these reports for growth direction and Kline’s channel data for the US provider market, and not mixing them. For the US specifically, Straits Research estimates the physician-dispensed cosmeceuticals market at US$3.54 billion in 2026 and names Asia-Pacific as the fastest-growing region, at a forecast CAGR of 10.46%. These are forecasts from a market-research publisher, not reported sales.
Which brands lead, and which are rising
Kline’s Mid-Year 2026 Update names SkinCeuticals, ZO Skin Health and SkinBetter Scienceas continuing to command a significant share of US medical care provider sales in the first half of 2026. Alongside them, some of the fastest-growing brands were much smaller. Kline cites Hydrinity, Epicutis and Plated Skin Science as showing particularly strong momentum, tied to regenerative ingredients, procedure-adjacent products, microbiome support and simplified regimens.
Via TikTok
Canada looks different. Kline names Colorescience and SkinBetter Science among the strongest performers there, with Functionalab and Alastin also growing, while several established brands declined. The practical lesson is that scale did not guarantee momentum in 2026, and a brand’s position in one market does not carry over to another.
Kline’s analysis of the Galderma and ZO Skin Health deal adds one more data point: using 2025 data, it describes ZO Skin Health as holding a strong number-two position in the US medical care provider channel, and estimates that the combination would lift Galderma’s share of that channel by 12.7 percentage points to 19.0%.
The table below summarises how Kline and the other sources used here describe the brands named most often. Brands are listed alphabetically, and the order is not a ranking.
Brand | What the sources say about 2026 | Ownership or deal note |
Growth in Canada in H1 2026; upgraded Regenerating Skin Nectar launched in the US | Part of Galderma’s portfolio |
|
One of the strongest performers in Canada in H1 2026; strong Amazon growth during Prime Day 2026 | Acquired by RoundTable Healthcare Partners in 2026 |
|
One of the fastest-growing US brands in H1 2026; launched Hydrobiome Serum | Secured a US$25M growth investment in 2026 |
|
One of the fastest-growing US brands in H1 2026 | No deal reported in the sources reviewed |
|
Introduced NU-GEN Cellular Renewal Serum in the US | Acquired by Bridgepoint from Waldencast, valued at up to US$460M (June 2026) |
|
One of the fastest-growing US brands in H1 2026 | No deal reported in the sources reviewed |
|
Significant US share in H1 2026; strong performer in Canada | Acquired by L’Oréal (agreed September 2022) |
|
Significant US share in H1 2026; extended its P-TIOX peptide franchise | Part of L’Oréal’s Dermatological Beauty division |
|
Significant US share in H1 2026; described as number two in the US provider channel (2025 data) | Galderma agreed to acquire it at a US$1.5B enterprise value (October 2026) |
Ownership is consolidating
Several physician-dispensed brands have changed hands or been valued publicly over the past year, and the pace in 2026 has been notable.
Deal | Detail | Timing |
Galderma and ZO Skin Health | Agreement to acquire 100% at US$1.5B enterprise value; ZO had about US$330M net sales through June 2026, roughly 4.5 times annual sales | Announced October 2026 |
Puig and ISDIN | Acquisition of the remaining 50% for about €1.2B | September 2026 |
Bridgepoint and Obagi Medical | Acquired from Waldencast in a transaction valued at up to US$460M | June 2026 |
RoundTable Healthcare Partners and Colorescience | Acquisition | 2026 |
L’Oréal and Skinbetter Science | Acquisition of a physician-dispensed US brand with nearly US$95M in trailing-twelve-month sales | Agreed September 2022 |
Kline describes dermocosmetics and physician-dispensed skincare as the category that drew the most strategic attention in 2026 beauty M&A.
What the listed companies are reporting
Public results point the same way, with one caveat: these figures cover dermocosmetics sold through pharmacies and other channels, not only the US medical channel, so they are context and not a like-for-like comparison.
L'Oreal's Dermatological / Via @WWD
- L'Oréal: its Dermatological Beauty division, which includes La Roche-Posay, CeraVe and SkinCeuticals, grew 12.2% like-for-like to €1.87 billion in the third quarter of 2026.
- Puig: Group skincare sales slipped 0.8% to €135.3 million in the quarter, but dermocosmetics, led by Uriage, grew at a double-digit rate while premium skincare stayed soft.
ISDIN By PUIG
The contrast between double-digit dermocosmetics growth at the corporate level and a 6% US provider channel is worth noting. It suggests that much of the category’s momentum sits outside the US clinic channel, though the data above does not let us measure how much.
Where Patients Buy
Kline's consumer research shows why channel boundaries are blurring. According to its Aesthetic Skin Care Consumer Insights study for the US, 46% of consumers discover professional skincare through a physician or medical spa, and 24% make their first purchase in the office and later repurchase online. About 60% said their most recent professional skincare purchase was made outside the physician or medical spa or its online shop.
2026 American Academy Dermatology / Via @L'Oreal
On the sales side, Kline reports that US e-commerce for physician-dispensed brands grew at a strong double-digit rate in the first half of 2026, outpacing the provider channel. The e-commerce figures cover brand websites and third-party e-tailers such as Amazon, Dermstore, Bluemercury.com and Ulta.com, and are not tied back to the physician. In other words, the clinic is still where many patients start, but not necessarily where they keep buying.
Dermatological skincare now has its own dedicated category across major e-commerce platforms
What Wholesale Buyers Should Check Before Ordering
The points below are our reading of the data, not findings from the sources. They are what we would check before placing a wholesale order for physician-dispensed skincare.
Authorised supply and authenticity.
Price and channel policy.
Momentum as well as size.
Ownership and continuity.
Compliance and labelling for your market.
Support.
Questions to ask any supplier
Are you an authorised distributor for this brand, and can you provide documentation?
What are the batch codes and expiry dates on the stock you ship?
What are your minimum order quantities, lead times and reorder terms?
How do you handle returns, damaged goods and recalls?
Which markets do you ship to, and what documentation do you provide for customs and registration?
Frequently Asked Questions
What is medical-dispensed skincare? It is professional skincare sold mainly through dermatology, plastic surgery and medical aesthetics practices, where a provider recommends and often sells the products alongside treatments. It is also called physician-dispensed skincare.
How big is the US medical-dispensed skincare market? Published figures vary with definitions. Kline reports that the US medical care provider channel grew 6% in the first half of 2026. Global estimates for physician-dispensed cosmeceuticals in 2025 range from US$9.14 billion (Straits Research) to US$16.17 billion (Verified Market Reports).
Which brands lead US medical-dispensed skincare? Kline names SkinCeuticals, ZO Skin Health and SkinBetter Science as holding significant share of US medical care provider sales in the first half of 2026, with Hydrinity, Epicutis and Plated Skin Science among the fastest-growing smaller brands.
Can a retailer or clinic buy these products wholesale? Eligibility rules differ by brand and market, so ask the brand or its authorised supplier about account requirements before ordering.
Why does buying from an authorised source matter? Kline reports that US e-commerce for these brands is growing faster than the clinic channel, which increases the number of third-party sellers. Buying from a documented source lowers the risk of counterfeit, expired or improperly stored product.
Source Medical-Dispensed Skincare with SuperNova
If you are a wholesale buyer looking for physician-dispensed and professional skincare, contact SuperNova to discuss availability, minimum order quantities and shipping to your market.
Email: info@supernovaasia.com
💡
Methodology and limits
This article summarises publicly available information published between 2024 and October 2026, listed below. Kline’s full reports are paid products, so we used its published summaries and have not reproduced its proprietary data. Brand names appear because the sources name them, and their order does not imply a ranking. Market-size figures from different publishers use different definitions and should not be combined. Nothing here is legal, financial or regulatory advice, and deal terms and company results may change after publication.
Copyright © 2025, SuperNova Trading Limited. All Rights Reserved.
CONTACT
info@supernovaasia.com
+852 67452978
Room P, 4/F, Lladro Centre, 72 Hoi Yuen Road Kwun Tong Kowloon
SUBSCRIBE TO NEWSLETTER
ABOUT SUPERNOVA
CONTACT US
WhatsApp